Loading page
Loading page
Loading substance route
Doses exceeding 300 mg present increased risk of physical toxicity, particularly in opioid-naïve or smaller individuals. Tramadol carries additional hazards distinct from typical opioid use, including seizure risk and potential serotonin syndrome at higher doses.
Effects vary widely by individual, dose, and context.
The cognitive effects of tramadol can be broken down into several components which progressively intensify proportional to dosage. The general head space of codeine is described by many as one of intense euphoria, relaxation, anxiety suppression and pain relief.
The physical effects of tramadol can be broken down into three components which progressively intensify proportional to dosage.
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tramadol is considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence. Compulsive redosing is reported, and its ability to relieve stress and improve mood without significant impairment contributes to its abuse potential.
Physical dependence develops with chronic use. Withdrawal symptoms include both opioid-typical effects (body aches, diarrhea, nausea, tremors, sweating, tachycardia) and SNRI-related symptoms (numbness, tingling, paresthesia, tinnitus). Withdrawal typically lasts longer than other opioids, with acute symptoms persisting seven days or more compared to three to four days for similar compounds.
Doses over 300mg can be physically dangerous in non-tolerant or smaller users. Doses of 400mg or higher are potentially fatal for new users. Acute tramadol overdose is generally not life-threatening when taken alone, with most fatalities resulting from polysubstance overdose involving CNS depressants. Individuals with CYP2D6 gene duplications (ultra-rapid metabolizers) face increased risk of intoxication.
| Species | Route | Value |
|---|---|---|
| mouse | oral | 350 mg/kg |
Tramadol produces respiratory depression by direct action on brainstem respiratory centres; this effect is dose-dependent and becomes clinically significant at high doses or in combination with other depressants. Long-term use may be associated with diminished libido, apathy, and memory loss.
Acute cardiovascular effects include hypotension in susceptible individuals and mild QTc prolongation at higher doses; serious cardiac events are rare at typical doses.
Chronic opioid use may influence the hypothalamic-pituitary-adrenal and gonadal axes, with potential increases in serum prolactin and decreases in cortisol and testosterone.
Tramadol causes reduced gut motility and increased smooth muscle tone, resulting in constipation; this effect develops more slowly to tolerance than other opioid effects.
Caution is advised in patients with liver impairment due to hepatic metabolism of tramadol to its active metabolite.
Caution is advised in patients with kidney failure due to renal elimination of tramadol and its metabolites.
Hallucinations, confusion, delirium, and paranoia can occur at high doses or during overdose. Psychiatric symptoms including hallucinations, extreme anxiety, and panic attacks may also emerge during withdrawal. These effects are not typical at common doses.
Tramadol is established to lower the seizure threshold in humans, distinguishing it from other opioids. Seizures have been reported within the recommended dosage range, with risk increasing at doses above 300mg. Seizures occur in approximately half of acute poisoning cases. Risk is further elevated in patients with epilepsy, history of seizures, or concurrent use of other medications that lower seizure threshold. Grand mal seizures have been reported at doses as low as 100-400mg orally in rare cases.
Tramadol was developed in 1962 by researchers at Grünenthal, a German pharmaceutical company. Despite its early synthesis, the compound did not receive regulatory approval in Germany until 1977, when it entered the market under the trade name Tramal. Following its introduction, tramadol quickly…
Not internationally scheduled - WHO kept under surveillance but did not recommend international control (2002)
Officially requires prescription but practically available over-the-counter at many pharmacies in 50mg and 100mg tablets as well as IV ampules.
Legal for medical use under the Arzneimittelgesetz (AMG). Possession or sale without a valid prescription is illegal under the Suchtmittelgesetz (SMG).
Available in 50mg tablets and IV ampules over-the-counter at pharmacies without prescription.
Available from pharmacies without prescription. Typical cost approximately $1-2 USD for 10 capsules as of 2010.
Can be purchased over-the-counter at drug stores along with other opioid-containing medications.
Listed as controlled since October 2002 and requires prescription. Despite national control, tramadol remained widely abused, with nearly 70% of people treated at addiction facilities using the drug as of 2015.
Regulated as a prescription medication according to Anlage 1 AMVV (Arzneimittelverschreibungsverordnung). Not classified as a narcotic under the BtMG but requires medical authorization.
Reportedly available over-the-counter from pharmacies without prescription, though pricing may vary for tourists versus locals.
Regulated under S.I. No. 540/2003. Legal to possess and use only with a valid prescription from a licensed medical practitioner.
Available over-the-counter in 50mg and 100mg capsule forms as of 2003.
Not listed as a First Schedule drug under the Dangerous Drugs Act 1952. May still require prescription under pharmaceutical regulations.
Requires a prescription but is not classified as a scheduled narcotic substance. Available through pharmacies with medical authorization.
Not scheduled as a narcotic substance but classified as a prescription-only medication. Legal possession requires valid medical prescription.
Requires valid medical prescription for legal possession and use. Available through licensed pharmacies.
Not available over-the-counter. Controlled under poison legislation rather than drug control laws. Requires prescription for legal access.
Launched in 1992 and was one of the only opioids not requiring special prescription forms. Usage increased significantly from 2.1 to 570.6 defined daily doses per million people per day between 1992 and 1998.
Classified as a controlled substance since December 2007, in the same category as codeine and dextropropoxyphene. Unlike other scheduled opioids, a normal prescription can be used rather than special prescription forms.
As of May 2014, tramadol in 50mg and 100mg oral forms is available from pharmacies without prescription. Sold under the brand name Tramagesic.
Highly regulated with severe penalties. Only specialist surgeons can prescribe a maximum 4-week supply, with government review of each prescription. Possession without prescription can result in 4 years imprisonment. Tramadol is the strongest opioid available as morphine and codeine are banned.
Federally scheduled as of August 18, 2014 under the Controlled Substances Act. Prior to federal scheduling, several states independently controlled tramadol including Arkansas, Illinois, Kentucky, Massachusetts, New York, Oklahoma, and Wyoming. Possession without prescription is illegal.
Classified as a Prescription-Only Medicine since 2001 under the Poisons Standard. Requires a valid prescription to obtain legally.
Classified under Category B pharmaceutical regulations requiring a valid prescription for legal possession.
Classified under List A2 as a narcotic substance by ANVISA (Agência Nacional de Vigilância Sanitária). Requires prescription and is subject to controlled substance regulations.
Not listed in the Controlled Drugs and Substances Act but requires prescription under Schedule F of the Food and Drugs Regulations. Most pharmacies will not dispense without a prescription. A 2007 proposal to add tramadol to Schedule I was not enacted.
Available at some pharmacies without prescription though many require it. Sold in 50mg capsules and extended-release tablets up to 300mg.
Regularly sold over-the-counter at fair-sized pharmacies, particularly in Addis Ababa. Official regulatory status unclear but practical availability is unrestricted.
Classified as Schedule H (prescription-only) and brought under the Narcotic Drugs and Psychotropic Substances Act in April 2018 due to abuse concerns and links to criminal organizations.
Was widely available over-the-counter until late 2009 when the Ministry of Health prohibited non-prescription sales. Now manufactured domestically and available through pharmacies with prescription only.
Requires a simplified license to import for personal use, with a maximum 60-day supply permitted. Subject to customs inspection and possible review for reclassification.
Controlled as a narcotic substance grouped with other opiates. Requires a specialized prescription form to acquire legally, rather than a standard prescription.
Officially marked for prescription-sale only though enforcement varies by pharmacy. Possession without proper prescription can result in detention, arrest, or demands for bribes.
Available for purchase at major pharmacy chains without prescription in urban areas.
Officially requires prescription though enforcement varies. Personal drug possession has been decriminalized since 2001, applying to small quantities for personal use.
Widely available over-the-counter. Sold as Tramasec brand (tramadol HCl 50mg capsules) manufactured in India.
Classified as a Schedule 5 controlled substance for prescribed medical use only. Sale and possession without prescription is decriminalized and treated as a misdemeanor rather than a criminal offense.
Difficult to obtain without proper prescription. Available through strict government-run medical stores with drugs imported from India.
Listed as a Category A pharmaceutical requiring a medical prescription. Available through licensed pharmacies with valid prescription only.
Classified as a 'green prescription' medication indicating controlled status. Illegal to sell or possess without a valid medical prescription.
Classified as a Class C drug under the Misuse of Drugs Act as of June 10, 2014. Previously available as a prescription-only medicine without controlled substance status. Annual tramadol-related deaths declined following scheduling.
11 sources cited
